Robotic Microtool Control in an Intelligent Automated In Vitro Fertilization and Intracytoplasmic Sperm Injection Platform
US-2024426856-A1 · Dec 26, 2024 · US
US9594077B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9594077-B2 |
| Application number | US-201314412318-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 3, 2013 |
| Priority date | Jul 3, 2012 |
| Publication date | Mar 14, 2017 |
| Grant date | Mar 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a new apparatus/system for determining fertility of mammalian sperm based on a specific sperm-binding test that mimics sperm binding to an egg. The inventive apparatus/system comprises surface-modified beads with a compound or conjugates containing a carbohydrate sequence associated with the mammalian zona-pellucida (ZP) glycoproteins.
Opening claim text (preview).
What claimed is: 1. A method of evaluating the ability of non-human mammalian sperm to bind to a mammalian egg, the method comprising: (a) combining a sample of non-human mammalian sperm, a media that is conducive to maintaining the physiological activity of the sperm, and at least one substrate that comprises bovine thyroglobulin on at least a portion of its surface, to allow for at least a portion of the sample of non-human mammalian sperm to bind to the substrate, wherein the binding of sperm to the substrate is indicative of the binding of sperm to a mammalian egg; and (b) visualizing or quantitating the sperm bound to the substrate, thereby evaluating the ability of non-human mammalian sperm to bind to a mammalian egg. 2. The method of claim 1 further comprising removing at least a portion of the unbound sperm before visualizing or quantitating the sperm bound to the substrate. 3. The method of claim 1 wherein the substrate comprises a crosslinked agarose bead. 4. The method of claim 1 wherein the compound or conjugate is attached to the surface of a specimen slide, dish, or well of a microtiter plate. 5. The method of claim 1 wherein the compound or conjugate is fixed for use in flow cytometry. 6. The method of claim 1 , wherein the mammalian sperm is equine or porcine. 7. The method of claim 1 , wherein the mammalian sperm is porcine.
Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum · CPC title
Infertility, e.g. sperm disorder, ovulatory dysfunction · CPC title
for testing the pathological state of an organism · CPC title
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q) · CPC title
Animal cells · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.